Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMGP.L Regulatory News (MGP)

  • There is currently no data for MGP

Disposal

19 Sep 2006 14:55

Mercury Group PLC19 September 2006 MERCURY GROUP PLC DISPOSAL OF NAVITAS HEMWAY LIMITED 19 September 2006 Further to the trading update announced on 4th September 2006, The Board ofMercury Group plc ("the Company") is pleased to announce today a further step inthe planned turnaround of the Company with the disposal of its facilitiesmanagement subsidiary Navitas Hemway Limited ("Navitas"), to Cornshell Limited,the buy-out vehicle wholly owned by the managing director of Navitas, Mr DavidDawson. Following the disposal of Navitas, the Company will focus on growing anddeveloping SMPA, its core commercial property agency, based in London. Inaddition, steps have been taken to continue the reduction of the Group'soverheads. The consideration for the disposal is £150,000 in cash, of which £100,000 ispayable on completion and a further £50,000 of deferred consideration is payablein instalments within one year following completion. In addition, intra-groupdebt of approximately £20,000 will be repaid to the Company. The disposalproceeds will be applied in improving working capital. The resulting loss ondisposal of approximately £2.4 million represents substantially the goodwillarising on the acquisition of Navitas in 2004. Navitas reported sales in the year ended 30 September 2005 of £2.4 million and aprofit before tax of £306,000. Since that date however, the trading performanceof Navitas has been well below management's expectations and it has continued toabsorb cash due to trading losses compounded by difficulties in collectingsubstantial debtors. Navitas had net assets of £215,000 at 31 March 2006. Under the AIM rules, the disposal of Navitas represents a transaction with arelated party, by virtue of the interest of David Dawson as the managingdirector of Navitas. In compliance with this requirement, the directors of theCompany consider, having consulted with its nominated adviser KBC Peel Hunt,that the terms of the transaction are fair and reasonable insofar asshareholders are concerned. The Board continues to explore the raising of additional capital by way of ashare placing with its principal shareholders and a further announcement on thiswill be made in due course. Contact: James Lugg 0207 393 4020 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th May 20213:27 pmRNSDirector/PDMR Shareholding
28th May 20212:43 pmRNSDirector/PDMR Shareholding
25th May 20217:00 amRNSPosting of Annual Report and Notice of AGM
11th May 20217:10 amRNSNon-Executive Director Change
11th May 20217:10 amRNSResults for the year ended 31 December 2020
20th Apr 20219:30 amRNSHolding(s) in Company
16th Apr 20219:47 amRNSHolding(s) in Company
29th Mar 202110:48 amRNSHolding(s) in Company
25th Mar 20218:05 amRNSCompletion of Acquisition & Director/PDMR Dealings
23rd Mar 20219:31 amRNSCorrection: Results of Fundraise and TVR
23rd Mar 20217:00 amRNSResults of Fundraise and Total Voting Rights
23rd Mar 20217:00 amRNSRe-release: Proposed acquisition of US-based RadMD
22nd Mar 20215:07 pmRNSProposed Fundraise to raise approximately £16m
22nd Mar 20215:07 pmRNSProposed acquisition of US-based RadMD
19th Mar 20217:00 amRNSMicrosoft Research’s Dr Junaid Bajwa joins as NED
22nd Feb 20217:00 amRNSMedica and Integral Diagnostics establish JV, MedX
11th Feb 202110:09 amRNSHolding(s) in Company
29th Jan 20219:02 amRNSHolding(s) in Company
26th Jan 20217:00 amRNSAppointment of Liberum as Joint Corporate Broker
21st Jan 20217:00 amRNSTrading Update
18th Jan 20217:00 amRNSDr. Robert Lavis appointed Group Medical Director
4th Dec 202011:57 amRNSDirector/PDMR Shareholding
2nd Dec 20209:31 amRNSDirector/PDMR Shareholding
1st Dec 20209:34 amRNSHolding(s) in Company
18th Nov 20204:41 pmRNSSecond Price Monitoring Extn
18th Nov 20204:36 pmRNSPrice Monitoring Extension
12th Nov 20207:00 amRNSDirector/PDMR Shareholding
11th Nov 202012:41 pmRNSHolding(s) in Company
10th Nov 20201:56 pmRNSHolding(s) in Company
6th Nov 20202:26 pmRNSHolding(s) in Company
5th Nov 20207:00 amRNSDirector/PDMR Shareholding
4th Nov 20207:00 amRNSMedica acquires Global Diagnostics Ireland
27th Oct 20209:20 amRNSHolding(s) in Company
22nd Oct 20209:41 amRNSHolding(s) in Company
16th Oct 202011:26 amRNSHolding(s) in Company
7th Oct 202012:34 pmRNSHolding(s) in Company
16th Sep 20201:07 pmRNSDeclaration of Dividend
14th Sep 20207:00 amRNSInterim results demonstrate resilient performance
9th Sep 202010:36 amRNSHolding(s) in Company
25th Aug 20204:41 pmRNSSecond Price Monitoring Extn
25th Aug 20204:36 pmRNSPrice Monitoring Extension
14th Aug 20209:56 amRNSHolding(s) in Company
21st Jul 202010:49 amRNSHolding(s) in Company
8th Jul 20207:00 amRNSTrading Update
11th Jun 20203:22 pmRNSDirector/PDMR Shareholding
1st Jun 20204:54 pmRNSIssue of Equity
28th May 202010:14 amRNSHolding(s) in Company
21st May 202012:55 pmRNSHolding(s) in Company
20th May 20204:25 pmRNSResult of AGM
20th May 20207:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.